摘要 |
The invention relates to thieno[3,4-b]pyrazine derivatives of Formula (I) and their pharmaceutically acceptable salts thereof, pharmaceutical compositions containing the compounds of the invention. The invention also relates to methods for treating, preventing and/or managing diseases, disorders, syndromes or conditions associated with inadequate insulin secretion such as diabetes, related disorders and metabolic syndrome. The invention also relates to methods for treating, preventing and/or managing diseases, disorders, syndromes or conditions which are affected or facilitated by the modulation of GLP-1 receptor. The invention also relates to processes for the preparation of the compounds of Formula (I). |
申请人 |
LUPIN LIMITED;SINDKHEDKAR, MILIND, DATTATRAYA;SAHA, NABENDU, NILMANI;DEEPAK, UKIRDE;SACHCHIDANAND, SACHCHIDANAND;PALLE, VENKATA, P.;KAMBOJ, RAJENDER, KUMAR |
发明人 |
SINDKHEDKAR, MILIND, DATTATRAYA;SAHA, NABENDU, NILMANI;DEEPAK, UKIRDE;SACHCHIDANAND, SACHCHIDANAND;PALLE, VENKATA, P.;KAMBOJ, RAJENDER, KUMAR |